Showing results (341-350 of 362) with videos related to
Sort By:
Pageof 37
The Journal of Clinical Endocrinology and Metabolism|October 18, 2017
Differential Growth Rates of Benign vs. Malignant Thyroid NodulesTrevor E Angell, Chirag M Vyas, Marco Medici, et al.Journal of Virology|February 4, 2025
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearanceTin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.Biorxiv : the Preprint Server for Biology|September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearanceTin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.Journal of Medicinal Chemistry|April 2, 2005
Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11Mark G Saulnier, Balu N Balasubramanian, Byron H Long, et al.Journal of Medicinal Chemistry|October 14, 2009
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinasesAshvinikumar V Gavai, Brian E Fink, David J Fairfax, et al.Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Duration of viable virus shedding in SARS-CoV-2 omicron variant infectionJulie Boucau, Caitlin Marino, James Regan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2021
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After VaccinationCrystal M North, Amy Barczak, Robert H Goldstein, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 14, 2019
CD82 controls CpG-dependent TLR9 signalingNida S Khan, Daniel P Lukason, Marianela Feliu, et al.Nature Microbiology|January 3, 2024
Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STINGHannah Brown Harding, Geneva N Kwaku, Christopher M Reardon, et al.JAMA Network Open|September 25, 2024
Emerging SARS-CoV-2 Resistance After Antiviral TreatmentTrevor J Tamura, Manish C Choudhary, Rinki Deo, et al.Pageof 37